CD79A and nasopharyngeal carcinoma: The positive rates of anti‐EAD IgA and IgG, anti‐EAR IgA and IgG, and anti‐TK IgG were lower than 50% in the non‐NPC participants with elevated EBNA1/IgA and VCA/IgA (Table 1).